Microbot Medical Inc. (MBOT)
NASDAQ: MBOT
· Real-Time Price · USD
3.06
-0.07 (-2.24%)
At close: Aug 15, 2025, 2:52 PM
Microbot Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.5M | -2.6M | -3.39M | -3.21M | -2.46M | -2.37M | -3.15M | -2.45M | -2.29M | -2.85M | -3M | -3.47M | -3.51M | -3.19M | -3.86M | -2.56M | -2.51M | -2.39M |
Depreciation & Amortization | 12K | 15K | 26K | 23K | 14K | 28K | 35K | 20K | 26K | 25K | 33K | 25K | 23K | 21K | 28K | 16K | 14K | 18K |
Stock-Based Compensation | 237K | 256K | 282K | 283K | 331K | 453K | 298K | 336K | 349K | 412K | 430K | 461K | 432K | 429K | 370K | 307K | 299K | 410K |
Other Working Capital | n/a | -544K | 1.39M | 152K | -72K | -765K | 178K | 505K | 66K | -760K | 79K | 28K | -66K | -269K | 573K | 56K | -98K | -34K |
Other Non-Cash Items | 678K | n/a | 1K | -687K | 235K | 235K | 822K | -70K | -8K | -27K | -7K | -1K | n/a | 1K | 1K | n/a | -1K | -34K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -544K | 1.39M | 837K | -72K | -765K | 178K | 505K | 66K | -760K | 79K | 28K | -66K | -269K | 573K | 56K | -98K | n/a |
Operating Cash Flow | -2.57M | -2.87M | -1.69M | -2.76M | -1.96M | -2.42M | -1.82M | -1.66M | -1.85M | -3.2M | -2.46M | -2.96M | -3.12M | -3.01M | -2.89M | -2.18M | -2.3M | -1.99M |
Capital Expenditures | -9K | -13K | -7K | n/a | -4K | -14K | 5K | -28K | -10K | n/a | -1K | -5K | -62K | -16K | -44K | -14K | -6K | -5K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -3.29K | 2K | 1.28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -3.8M | -28.12M | n/a | n/a | n/a | -5.12M | -1.68M | -5.18M | -2.56M | -638K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 2.5M | 3.3M | 1.5M | 140K | 1.19M | 3.85M | 4.63M | 2.64M | 1.27M | 3.52M | n/a | n/a | n/a | n/a | 3M | n/a | n/a | 270K |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 1.28K | n/a | -1.28K | 3K | -3.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -1.31M | -24.83M | 1.5M | 140K | 1.19M | -1.28M | 2.96M | -2.57M | -1.29M | 2.88M | -3.75M | -5K | -62K | -16K | 2.96M | -14K | -6K | 265K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | 161.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.38M | n/a | n/a | n/a |
Financial Cash Flow | 4.75M | 27.81M | 2.83M | 633K | 2.07M | 2.4M | n/a | -161K | 6.72M | n/a | 4.32M | n/a | n/a | n/a | -3.38M | n/a | n/a | n/a |
Net Cash Flow | 870K | 102K | 2.64M | -1.99M | 1.3M | -1.31M | 1.14M | -4.39M | 3.57M | -320K | -1.89M | -2.96M | -3.19M | -3.02M | 68K | -2.19M | -2.3M | -1.73M |
Free Cash Flow | -2.58M | -2.89M | -1.7M | -2.76M | -1.96M | -2.43M | -1.82M | -1.68M | -1.86M | -3.2M | -2.46M | -2.96M | -3.19M | -3.02M | -2.93M | -2.19M | -2.3M | -2M |